ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model

医学 血管生成 缺血 CD146号 治疗性血管生成 背景(考古学) 正电子发射断层摄影术 体内 灌注 严重肢体缺血 肢体灌注 动脉发生 新生血管 病理 股动脉 血流 结扎 血管疾病 心脏病学 核医学 内科学 动脉疾病 干细胞 古生物学 生物技术 生物 遗传学 川地34
作者
Carolina A. Ferreira,Reinier Hernandez,Yunan Yang,Hector F. Valdovinos,Jonathan W. Engle,Weibo Cai
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
卷期号:15 (8): 3434-3441 被引量:11
标识
DOI:10.1021/acs.molpharmaceut.8b00424
摘要

Peripheral arterial disease (PAD) consists of a persistent obstruction of lower-extremity arteries further from the aortic bifurcation attributable to atherosclerosis. PAD is correlated with an elevated risk of morbidity and mortality as well as of deterioration of the quality of life with claudication and chronic leg ischemia being the most frequent complications. Therapeutic angiogenesis is a promising therapeutic strategy that aims to restore the blood flow to the ischemic limb. In this context, assessing the efficacy of pro-angiogenic treatment using a reliable noninvasive imaging technique would greatly benefit the implementation of this therapeutic approach. Herein, we describe the angiogenesis and perfusion recovery characteristics of a mouse model of PAD via in vivo positron emission tomography (PET) imaging of CD146 expression. For that, ischemia was generated by ligation and excision of the right femoral artery of Balb/C mice and confirmed through laser Doppler imaging. The angiogenic process, induced by ischemia, was noninvasively monitored and quantified through PET imaging of CD146 expression in the injured leg using a 64Cu-labeled anti-CD146 monoclonal antibody, 64Cu-NOTA-YY146, at post-operative days 3, 10, and 17. The CD146-specific character of 64Cu-NOTA-YY146 was verified via a blocking study performed in another cohort at day 10 after surgery. Tracer uptake was correlated with in situ CD146 expression by histological analysis. PET scan results indicated that 64Cu-NOTA-YY146 uptake in the injured leg was significantly higher, with the highest uptake with a value of 14.1 ± 2.0 %ID/g at post-operative day 3, compared to the normal contralateral hindlimb, at all time points (maximum uptake of 2.2 ± 0.2 %ID/g). The pre-injection of a blocking dose resulted in a significantly lower tracer uptake in the ischemic hindlimb on day 10 after surgery, confirming tracer specificity. CD146/CD31 immunofluorescent co-staining showed an excellent correlation between the high uptake of the tracer with in situ CD146 expression levels and a marked co-localization of CD146 and CD31 signals. In conclusion, persistent and CD146-specific tracer accumulation in the ischemic hindlimb was observed, confirming the feasibility of 64Cu-NOTA-YY146 to be used as an imaging agent to monitor the progression of angiogenesis and recovery in future PAD research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wynne的应助被美丽采纳,获得20
1秒前
1秒前
斯文败类的应助被Jared采纳,获得10
1秒前
2秒前
Young离子完成签到 ,获得积分10
3秒前
zyy发布了新的文献求助10
3秒前
why完成签到,获得积分10
3秒前
4秒前
Lee发布了新的文献求助10
4秒前
zsg发布了新的文献求助10
5秒前
Sicily完成签到,获得积分10
5秒前
JamesPei的应助被张会采纳,获得10
5秒前
6秒前
7秒前
7秒前
7秒前
Sicily发布了新的文献求助10
8秒前
zhoushuai发布了新的文献求助10
8秒前
负责念梦完成签到,获得积分10
8秒前
王德荣发布了新的文献求助10
8秒前
英俊的铭的应助被缓慢半山采纳,获得10
8秒前
lyn完成签到,获得积分10
8秒前
11111完成签到,获得积分10
9秒前
forever完成签到,获得积分10
9秒前
或大或小发布了新的文献求助10
9秒前
10秒前
玊尔玉完成签到,获得积分20
11秒前
lyn发布了新的文献求助10
11秒前
11秒前
11秒前
灵运完成签到,获得积分10
11秒前
pray完成签到,获得积分10
11秒前
12秒前
xixihaha发布了新的文献求助10
12秒前
情怀的应助被zyy采纳,获得30
12秒前
Nana完成签到,获得积分10
13秒前
无花果的应助被xiaobai采纳,获得10
13秒前
13秒前
鲤鱼鑫磊发布了新的文献求助10
14秒前
SSSYYY完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820